AstraZeneca Pharma India Limited (BOM: 506820)

AstraZeneca Pharma India Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	4,968	5,056	5,003	4,484	3,523	835
Short-Term Investments	-	-	-	-	-	1,690
Cash & Short-Term Investments	4,968	5,056	5,003	4,484	3,523	2,525
Cash Growth	-4.51%	1.05%	11.58%	27.27%	39.54%	45.75%
Accounts Receivable	1,498	1,531	1,075	858.9	851.9	832.1
Other Receivables	-	160.4	105.1	121.8	56.6	115.7
Receivables	1,501	1,693	1,181	981.6	911.2	955.8
Inventory	3,820	2,279	1,902	1,402	1,598	1,652
Prepaid Expenses	-	109.6	117.7	108.2	83.9	82.8
Other Current Assets	376.7	190	150.4	80.5	71.1	208.1
Total Current Assets	10,665	9,327	8,355	7,057	6,188	5,423
Property, Plant & Equipment	674.6	648.4	701.9	766.9	849.8	957.7
Other Intangible Assets	19	21.1	-	-	-	-
Long-Term Deferred Tax Assets	377.8	212.5	206.7	163	145.3	146.4
Other Long-Term Assets	673.9	568.5	576.6	574.9	560.1	497.3
Total Assets	12,413	10,780	9,849	8,566	7,747	7,064
Accounts Payable	3,169	1,965	2,279	1,904	1,784	2,097
Accrued Expenses	-	767.2	852.3	785.3	736.6	867.4
Current Portion of Leases	37.9	18.1	35.2	36.1	35.1	25.4
Current Income Taxes Payable	25.6	66.6	24.2	49.4	56.3	21
Current Unearned Revenue	-	490.5	398	306.9	128.3	86.2
Other Current Liabilities	1,516	263.7	250.8	244.4	295	175.2
Total Current Liabilities	4,748	3,571	3,839	3,327	3,035	3,272
Long-Term Leases	133.3	27.8	36.9	50.2	86.3	93
Other Long-Term Liabilities	737.9	17.7	16.6	26.8	23.3	23.1
Total Liabilities	5,620	3,661	3,962	3,452	3,185	3,419
Common Stock	50	50	50	50	50	50
Retained Earnings	-	6,313	5,088	4,321	3,772	2,855
Comprehensive Income & Other	6,744	756.4	749.2	743	739.4	739.4
Shareholders' Equity	6,794	7,119	5,887	5,114	4,562	3,644
Total Liabilities & Equity	12,413	10,780	9,849	8,566	7,747	7,064
Total Debt	171.2	45.9	72.1	86.3	121.4	118.4
Net Cash (Debt)	4,797	5,010	4,931	4,398	3,402	2,407
Net Cash Growth	-6.84%	1.59%	12.13%	29.27%	41.36%	38.92%
Net Cash Per Share	191.90	200.39	197.25	175.92	136.08	96.26
Filing Date Shares Outstanding	25	25	25	25	25	25
Total Common Shares Outstanding	25	25	25	25	25	25
Working Capital	5,917	5,756	4,515	3,730	3,153	2,151
Book Value Per Share	271.70	284.77	235.48	204.56	182.47	145.78
Tangible Book Value	6,775	7,098	5,887	5,114	4,562	3,644
Tangible Book Value Per Share	270.94	283.92	235.48	204.56	182.47	145.78
Land	-	4.9	4.9	4.9	4.9	4.9
Buildings	-	427	421.3	415.2	383.4	332.8
Machinery	-	1,208	1,154	1,082	1,023	835.9
Construction In Progress	-	2.7	13.3	22	40.2	242.4

Source: S&P Capital IQ. Standard template. Financial Sources.